Antimicrobial Resistance

iStock/megaflopp

Explore our policy work on AMR

The threat of antimicrobial resistance (AMR) has now been recognised globally and it is estimated that 10 million people a year will die due to antimicrobial resistance by 2050 if no urgent action is taken. Explore more of the Microbiology Society’s policy work on antimicrobial resistance below.

Consultation responses

NHS England: Antimicrobial Products Subscription Model Consultation

The Microbiology Society submitted a written response to a consultation launched by NHS England, in collaboration with the National Institute for Health and Care Excellence (NICE) and the Department of Health and Social Care (DHSC), on the expansion of the piloted subscription-style payment model for antimicrobial products..
Department of Health and Social Care: Antimicrobial Resistance National Action Plan Inquiry

The Microbiology Society submitted a response to a call for evidence launched by the Department of Health and Social Care. This inquiry seeks to establish key priority areas for government intervention, and to gather expert knowledge to inform the new action plan and improve existing policies.
House of Commons Science and Technology Committee: The Antimicrobial Potential of Bacteriophages Inquiry

The Microbiology Society submitted a response to a call for evidence launched by the House of Commons Science and Technology Committee on the antimicrobial potential of bacteriophages. The inquiry seeks to establish the strengths and weaknesses of bacteriophage therapy and identify opportunities for the UK government to adapt and improve existing policies.
Evaluation of the EU Antimicrobial Resistance Action Plan

The Microbiology Society submitted a letter in response to the public consultation for the Evaluation of the Commission’s Communication to the European Parliament and the Council on the Action Plan against the Rising Threats from Antimicrobial Resistance (AMR) (COM (2011) 748).
House of Commons Health and Social Care Committee: Antimicrobial Resistance Inquiry (2018)

The Microbiology Society submitted a written response jointly with the Society for Applied Microbiology to the Health and Social Care Select Committee’s Antimicrobial Resistance (AMR) Inquiry, which looked at what the UK AMR 2013-2018 Strategy has delivered and key actions and priorities for the next UK Government strategy.
House of Commons Science and Technology Committee: Antimicrobial Resistance Inquiry (2013)

The Microbiology Society responded to the House of Commons Select Committee on Science and Technology inquiry on antimicrobial resistance.

Briefings

Antimicrobial Resistance in the UK: Therapeutics and Vaccines

Antimicrobial resistance (AMR) is an urgent and devastating global health crisis that threatens our healthcare systems, economies, the environment and animal health. Microbiologists across the world are leading the way by working on new innovative solutions to AMR, including developing novel therapeutics and vaccines.
Antimicrobial Resistance in the UK: Diagnostics and Surveillance

Antimicrobial resistance (AMR) is an urgent and devastating global health crisis that threatens our healthcare systems, economies, the environment and animal health. Microbiologists across the world are leading the way by working on new innovative diagnostic solutions to AMR.
A Sustainable Future: Antimicrobial Resistance Policy Report

The current landscape of AMR research in the UK and Ireland is highly active and expansive. However, the challenge is significant and some aspects of the research must be augmented in order to provide new solutions to infections caused by antimicrobial-resistant organisms.
Antimicrobial Resistance Explainer

In 2015 the United Nations (UN) adopted the Sustainable Development Goals (SDGs), a set of targets for the world to achieve by 2030. AMR is a very real threat to achieving the UN SDGs, particularly those associated with poverty, food production, the environment and sustainable economic growth.

Position statements

LESPAR response to WHO Global Action Plan on Antimicrobial Resistance (2015)

The Learned Society Partnership on Antimicrobial Resistance (LeSPAR), which comprises the Microbiology Society, Royal Society of Chemistry, Biochemical Society, Society for Applied Microbiology, British Society for Antimicrobial Chemotherapy and Royal Society of Biology, published a statement in response to the approval of the World Health Organization Global Action Plan on AMR.

Image Credits

iStock/NiseriN

iStock/SweetBunFactory

iStock/Mykola Sosiukin

iStock/librededroit

iStock/lucadp

iStock/anyaivanova

iStock/BrasilNut1

iStock/Nicolae Malancea

iStock/AlexRaths

iStock/Alexey Koza

iStock/angelp